The Boland Lab at Massachusetts General Hospital leads correlative immuno-oncology efforts in melanoma and gastrointestinal malignancies.
Research & Clinical Trials
Research topics in the Cusack Laboratory include molecular targeted therapies for colorectal cancer, melanoma, Merkel cell cancer and carcinomatosis, and improving delivery of surgical cancer care in resource-limited settings.
The research mission of the Head and Neck Translational Immuno-Oncology Research Lab at Massachusetts General Hospital is to rapidly translate innovative, biomarker-driven immunotherapies that have the potential to improve treatment outcomes for patients with head and neck cancer.
The Cunningham Lab at Massachusetts General Hospital focuses on improving the quality of care for patients with thyroid, parathyroid and adrenal disorders.
The Laboratory of Gastrointestinal Epithelial Biology works to unravel the molecular mechanisms that underline the processes of growth and differentiation within intestinal epithelia, focusing on gut mucosal defense and how the host interacts with the intestinal microbiota.
The Liss Laboratory in the Division of Gastrointestinal and Oncologic Surgery at Massachusetts General Hospital is interested in understanding the molecular mechanisms that contribute to pancreatic cancer.
Research topics in the Maheswaran Lab include tumorigenesis, breast cancer and cancer genetics.
The Oncolytic Virus Laboratory at Massachusetts General Hospital seeks to understand how oncolytic viruses, a new class of tumor immunotherapy or cancer treatment, mediate antitumor activity.
The focus of the basic and translational laboratory efforts is the molecular mechanisms underlying the initiation, progression, and maintenance of pancreatic disease and cancer, specifically the contribution of developmental genes.
Research topics in the Tanabe Lab include hepatobiliary cancer, epidermal growth factor and hepatocellular carcinoma.